Rxsight
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $33,637 | $37,895 | $40,214 | $45,408 |
Gross Profit | 25,190 | 28,329 | 28,788 | 25,220 |
EBITDA | -14,003 | -10,674 | -5,398 | -5,179 |
EBIT | -11,459 | -5,921 | -6,320 | |
Net Income | -11,786 | -8,190 | -5,938 | -6,338 |
Net Change In Cash | 33,637 | 37,895 | 40,214 | 45,408 |
Free Cash Flow | -5,913 | -9,407 | -5,107 | -453 |
Cash | 40,355 | 28,000 | 16,706 | 16,720 |
Basic Shares | 40,743 | 40,509 | 40,356 | 39,788 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $139,927 | $89,077 | $49,005 | $22,593 |
Gross Profit | 98,943 | 53,765 | 21,328 | 4,517 |
EBITDA | -23,760 | -41,037 | -57,779 | -41,010 |
EBIT | -27,384 | -45,280 | -61,801 | -44,998 |
Net Income | -27,455 | -48,608 | -66,756 | -48,688 |
Net Change In Cash | 139,927 | 89,077 | 49,005 | 22,593 |
Cost of Revenue | -12,568 | 10,727 | ||
Free Cash Flow | -22,386 | -46,407 | -61,243 | -46,648 |
Cash | 16,706 | 9,692 | 11,834 | 24,361 |
Basic Shares | 38,867 | 34,455 | 27,661 | 27,366 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.29 |
2025-03-31 | -$0.03 |
2024-12-31 | $0.03 |
